JP2012516349A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516349A5
JP2012516349A5 JP2011548297A JP2011548297A JP2012516349A5 JP 2012516349 A5 JP2012516349 A5 JP 2012516349A5 JP 2011548297 A JP2011548297 A JP 2011548297A JP 2011548297 A JP2011548297 A JP 2011548297A JP 2012516349 A5 JP2012516349 A5 JP 2012516349A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
halogen
het
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548297A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012516349A (ja
JP5658688B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/022411 external-priority patent/WO2010088392A1/en
Publication of JP2012516349A publication Critical patent/JP2012516349A/ja
Publication of JP2012516349A5 publication Critical patent/JP2012516349A5/ja
Application granted granted Critical
Publication of JP5658688B2 publication Critical patent/JP5658688B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548297A 2009-01-28 2010-01-28 カルボキサミド化合物およびその使用方法 Expired - Fee Related JP5658688B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14798209P 2009-01-28 2009-01-28
US61/147,982 2009-01-28
PCT/US2010/022411 WO2010088392A1 (en) 2009-01-28 2010-01-28 Carboxamide compounds and methods for using the same

Publications (3)

Publication Number Publication Date
JP2012516349A JP2012516349A (ja) 2012-07-19
JP2012516349A5 true JP2012516349A5 (cg-RX-API-DMAC7.html) 2013-03-14
JP5658688B2 JP5658688B2 (ja) 2015-01-28

Family

ID=42061132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548297A Expired - Fee Related JP5658688B2 (ja) 2009-01-28 2010-01-28 カルボキサミド化合物およびその使用方法

Country Status (17)

Country Link
US (2) US8362235B2 (cg-RX-API-DMAC7.html)
EP (1) EP2391616B1 (cg-RX-API-DMAC7.html)
JP (1) JP5658688B2 (cg-RX-API-DMAC7.html)
KR (1) KR101693061B1 (cg-RX-API-DMAC7.html)
CN (1) CN102365275B (cg-RX-API-DMAC7.html)
AU (1) AU2010208247B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1007287B8 (cg-RX-API-DMAC7.html)
CA (1) CA2750835C (cg-RX-API-DMAC7.html)
EA (1) EA022083B1 (cg-RX-API-DMAC7.html)
ES (1) ES2581678T3 (cg-RX-API-DMAC7.html)
IL (1) IL214203A (cg-RX-API-DMAC7.html)
MX (1) MX2011007639A (cg-RX-API-DMAC7.html)
NZ (1) NZ594556A (cg-RX-API-DMAC7.html)
SG (1) SG172974A1 (cg-RX-API-DMAC7.html)
UA (1) UA106600C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010088392A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201105215B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009132136A1 (en) 2008-04-23 2009-10-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
US8796254B2 (en) 2010-03-31 2014-08-05 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds
HUE052110T2 (hu) 2010-07-29 2021-04-28 Rigel Pharmaceuticals Inc AMPK-t aktiváló heterociklusos vegyületek és alkalmazásuk
US9005909B2 (en) 2011-01-06 2015-04-14 Rigel Pharmaceuticals, Inc. Whole blood assay for measuring AMPK activation
US9409884B2 (en) 2012-02-01 2016-08-09 Rigel Pharmaceuticals, Inc. 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6064062B2 (ja) 2013-03-15 2017-01-18 ファイザー・インク Ampkを活性化させるインダゾール化合物
US20150087673A1 (en) * 2013-09-26 2015-03-26 Rigel Pharmaceuticals, Inc. Methods for using and biomarkers for ampk-activating compounds
US20160214967A1 (en) 2013-09-30 2016-07-28 The University Of Tokyo Activator of adiponectin receptor
EP3737361A4 (en) 2018-01-11 2021-08-25 Centaurus Therapeutics INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR THE TREATMENT OF DISEASES
US12194023B2 (en) 2018-11-29 2025-01-14 The Research Foundation For The State University Of New York Compositions and methods for modular control of bioorthogonal ligation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
KR100579792B1 (ko) 1998-05-13 2006-05-12 동화약품공업주식회사 신규 2,5-피리딘디카복실산 유도체
AU2001287898A1 (en) * 2000-09-22 2002-04-02 Stephen Garland Pyrazolopyridines and pyrazolopyridazines as antidiabetics
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
CA2634235A1 (en) * 2005-12-21 2007-07-05 Schering Corporation Combination of an h3 antagonist/inverse agonist and an appetite suppressant
DE602006021591D1 (de) 2006-12-11 2011-06-09 Genetics Co Inc Aromatische 1,4-DI-Carboxylamide und deren Verwendung
ES2627221T3 (es) * 2006-12-28 2017-07-27 Rigel Pharmaceuticals, Inc. Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso
GB0706793D0 (en) * 2007-04-05 2007-05-16 Evotec Ag Compounds
EP2231600B1 (en) 2007-11-16 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
EP2231666B1 (en) * 2007-12-12 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
WO2009132136A1 (en) * 2008-04-23 2009-10-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
US8796254B2 (en) 2010-03-31 2014-08-05 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds

Similar Documents

Publication Publication Date Title
JP2011503210A5 (cg-RX-API-DMAC7.html)
JP2011506480A5 (cg-RX-API-DMAC7.html)
TWI843712B (zh) K他命的前藥及其組成物及用途
ES2552733T3 (es) Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
EP2688403B1 (en) Opioid receptor ligands and methods of using and making same
JP6219507B2 (ja) キナーゼ阻害剤としてのアミノヘテロアリールベンズアミド
JP2013532692A5 (cg-RX-API-DMAC7.html)
EP3101015B1 (en) Heterocyclic sulfonamide derivative and medicine comprising same
WO2021043077A1 (zh) 一种取代吡嗪化合物、其制备方法和用途
JP2011527665A5 (cg-RX-API-DMAC7.html)
NO20091681L (no) Modulatorer av glukortikoidreseptoren, AP-1, og/eller NF-kappaB aktivitet og anvendelse derav
JP2010514788A5 (cg-RX-API-DMAC7.html)
ES2652664T3 (es) Anilinas sustituidas como antagonistas de CCR(4)
TW201024313A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
NO20091620L (no) Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2013533229A5 (cg-RX-API-DMAC7.html)
JP2010520893A5 (cg-RX-API-DMAC7.html)
CN106714793B (zh) 琥珀酸脱氢酶抑制剂(SDHi’s)
KR20180094938A (ko) 오피오이드 수용체 리간드와 시토크롬 p450 억제제의 결합
RU2010108943A (ru) Новые пиперазинамидные производные
CA2569654A1 (en) Benzimidazolone carboxylic acid derivatives
JP2007519742A5 (cg-RX-API-DMAC7.html)
US20230000840A1 (en) Therapeutic agents and prophylactic agents for functional gastrointestinal disorders and xerostomia
KR102766396B1 (ko) 복소환 술폰아미드 유도체 및 그것을 함유하는 의약